MEK1/2 kinases disable the tumor suppressor functions of native BCR and ABL1 kinases to impair anticancer drugs’ responsiveness in TKI-resistant Philadelphia positive leukemias
Congress of the Italian Society of Experimental Hematology (18th : Firenze, Italy : March 7-9, 2024) Haematologica . – Vol. 109 s1 (2024) . –…
Leggi di più
